全文获取类型
收费全文 | 48756篇 |
免费 | 5102篇 |
国内免费 | 2702篇 |
专业分类
耳鼻咽喉 | 462篇 |
儿科学 | 969篇 |
妇产科学 | 512篇 |
基础医学 | 4628篇 |
口腔科学 | 810篇 |
临床医学 | 7058篇 |
内科学 | 5830篇 |
皮肤病学 | 817篇 |
神经病学 | 2189篇 |
特种医学 | 1532篇 |
外国民族医学 | 16篇 |
外科学 | 3005篇 |
综合类 | 10017篇 |
现状与发展 | 9篇 |
一般理论 | 6篇 |
预防医学 | 4912篇 |
眼科学 | 1249篇 |
药学 | 5918篇 |
97篇 | |
中国医学 | 3299篇 |
肿瘤学 | 3225篇 |
出版年
2025年 | 11篇 |
2024年 | 597篇 |
2023年 | 861篇 |
2022年 | 1966篇 |
2021年 | 2574篇 |
2020年 | 2141篇 |
2019年 | 1525篇 |
2018年 | 1602篇 |
2017年 | 1720篇 |
2016年 | 1471篇 |
2015年 | 2363篇 |
2014年 | 3069篇 |
2013年 | 3012篇 |
2012年 | 4434篇 |
2011年 | 4631篇 |
2010年 | 3309篇 |
2009年 | 2762篇 |
2008年 | 3002篇 |
2007年 | 2841篇 |
2006年 | 2550篇 |
2005年 | 2114篇 |
2004年 | 1554篇 |
2003年 | 1444篇 |
2002年 | 1076篇 |
2001年 | 908篇 |
2000年 | 715篇 |
1999年 | 540篇 |
1998年 | 297篇 |
1997年 | 285篇 |
1996年 | 187篇 |
1995年 | 164篇 |
1994年 | 145篇 |
1993年 | 76篇 |
1992年 | 112篇 |
1991年 | 84篇 |
1990年 | 56篇 |
1989年 | 60篇 |
1988年 | 37篇 |
1987年 | 39篇 |
1986年 | 26篇 |
1985年 | 34篇 |
1984年 | 14篇 |
1983年 | 10篇 |
1982年 | 10篇 |
1981年 | 17篇 |
1979年 | 13篇 |
1978年 | 9篇 |
1975年 | 10篇 |
1974年 | 9篇 |
1973年 | 11篇 |
排序方式: 共有10000条查询结果,搜索用时 0 毫秒
1.
2.
Javed Butler Mei Yang Massimiliano Alfonzo Manzi Gregory P. Hess Mahesh J. Patel Thomas Rhodes Michael M. Givertz 《Journal of the American College of Cardiology》2019,73(8):935-944
Background
Epidemiology of patients with worsening heart failure and reduced ejection fraction (HFrEF) in the real-world setting is not well described.Objectives
The purpose of this study was to describe incidence, clinical characteristics, treatment, and outcomes of patients with HFrEF who develop worsening heart failure (HF) in the real-world setting.Methods
Data on patients with incident HFrEF from the National Cardiovascular Data Registry PINNACLE were linked to pharmacy, private practitioner, and hospital claims databases. Incidence, clinical characteristics, treatment (angiotensin-converting enzyme inhibitor/angiotensin receptor blocker, beta-blocker, and mineralocorticoid receptor antagonist) and outcomes of patients with worsening HF, defined as ≥90 days of stable HF with subsequent worsening requiring intravenous diuretic agents, were assessed.Results
Of 11,064 HFrEF patients, 1,851 (17%) developed worsening HF on average 1.5 years following initial HF diagnosis. Patients who developed worsening HF were more likely to be African American, be octogenarians, and have higher comorbidity burden (p < 0.001). At the onset of worsening HF, 42.4% of patients were on monotherapy, 43.4% were on dual therapy, and 14.1% were on triple therapy. A total of 48%, 61%, and 98% of patients were on >50% target dose for angiotensin-converting enzyme inhibitor/angiotensin receptor blocker, beta-blocker, and mineralocorticoid receptor antagonist, respectively. The 2-year mortality rate was 22.5%, and 56% of patients were rehospitalized within 30 days of the worsening HF event.Conclusions
In the real-world setting, 1 in 6 patients with HFrEF develop worsening HF within 18 months of HF diagnosis. These patients have a high risk for 2-year mortality and recurrent HF hospitalizations. The use of standard-of-care therapies both before and after the onset of worsening HF is low. With high unmet medical need, patients with worsening HF require novel treatment strategies as well as greater optimization of existing guideline-directed therapy. 相似文献3.
4.
Yun Chen Na Wang Xiaolian Dong Jianfu Zhu Yue Chen Qingwu Jiang Chaowei Fu 《Nutrition, metabolism, and cardiovascular diseases : NMCD》2021,31(8):2416-2425
Background and aimsSome amino acids (AAs) may be associated with type 2 diabetes (T2DM). This study aimed to determine the associations of individual AAs with the development of T2DM in rural Chinese adults.Methods and resultsA cohort study of 1199 individuals aged 18 years or older was conducted from 2006 to 2008 in a rural community of Deqing, China, a repeated survey was done in 2015 and data linkage with the electronic health records system was performed each year for identifying new T2DM cases. A high-performance liquid chromatography approach was used to measure the baseline serum concentrations of 15 AAs. Cox proportional hazards models were used to examine the associations between AAs and the risk of incident T2DM. A total of 98 new T2DM cases were identified during the follow-up of 12 years on average. Among 15 AAs, proline was associated with an increased risk of incident T2DM after adjusted for age, sex, body mass index, fasting plasma glucose, family history of T2DM, smoking status, alcohol use, and history of hypertension, the adjusted hazard ratio for 1-standard deviation increment was 1.20 (95% confidence interval: 1.00, 1.43). The association tended to be more marked in subjects younger than 60 years and overweight/obese subjects. Among participants without hypertension, proline and phenylalanine were associated with an increased risk of incident T2DM, while aspartic acid was associated with a decreased risk.ConclusionSerum proline was associated with the risk of incident T2DM in rural Chinese adults and might be a potential predictor. 相似文献
5.
6.
Ulfuara Shefa Na Young Jeong In Ok Song Hyung-Joo Chung Dokyoung Kim Junyang Jung Youngbuhm Huh 《中国神经再生研究》2019,(5)
Mitophagy is activated by a number of stimuli, including hypoxia, energy stress, and increased oxidative phosphorylation activity. Mitophagy is associated with oxidative stress conditions and central neurodegenerative diseases. Proper regulation of mitophagy is crucial for maintaining homeostasis; conversely, inadequate removal of mitochondria through mitophagy leads to the generation of oxidative species, including reactive oxygen species and reactive nitrogen species, resulting in various neurodegenerative diseases, such as Alzheimer's disease, Parkinson's disease, Huntington's disease, and amyotrophic lateral sclerosis. These diseases are most prevalent in older adults whose bodies fail to maintain proper mitophagic functions to combat oxidative species. As mitophagy is essential for normal body function, by targeting mitophagic pathways we can improve these disease conditions. The search for effective remedies to treat these disease conditions is an ongoing process, which is why more studies are needed. Additionally, more relevant studies could help establish therapeutic conditions, which are currently in high demand. In this review, we discuss how mitophagy plays a significant role in homeostasis and how its dysregulation causes neurodegeneration. We also discuss how combating oxidative species and targeting mitophagy can help treat these neurodegenerative diseases. 相似文献
7.
Kyle L. Thompson Mei Chung Deepa Handu Melissa Gutschall Sarah T. Jewell Laura Byham-Gray J. Scott Parrott 《Journal of the Academy of Nutrition and Dietetics》2019,119(5):799-817.e43
Background
Nutrition specialists are considered key members of multicomponent pediatric weight management intervention teams, but to date, their contribution has not been quantified.Objective
The purpose of this systematic review was to estimate the effectiveness of interventions provided by treatment teams that include a nutrition specialist on pediatric weight management outcomes, including body mass index (BMI), BMI z score, and waist circumference when compared with treatment teams that do not include a nutrition specialist.Methods
The results of a comprehensive literature search and a systematic and more targeted update of that search were included in the meta-analyses: a search of controlled trials published between July 2005 and April 2012, conducted during the 2015 Pediatric Weight Management Update Project of the Academy of Nutrition and Dietetics Evidence Analysis Library, and an update search of controlled trials published between May 2012 and December 2015 focusing on a more specific topic within the previous search. Studies included overweight and/or obese patients aged 6 to 18 years receiving outpatient weight management treatment. Data extraction of all studies identified was performed using a standardized tool. The resulting data from the search and the systematic update were merged. Ninety-nine studies and 209 study arms were included in the analysis. An exploratory meta-analysis using alternative meta-analytic methods designed for complex, heterogenous interventions was conducted to identify relative contributions by intervention provider category at selected time points. Meta-regression analyses were used to evaluate significant differences from the reference category for each provider category.Results
The nutrition specialist-only condition resulted in increased reductions in BMI z score compared with behavioralist-only, combined nutrition specialist and behavioralist, and neither nutrition specialist or behavioralist category (reference) throughout the analysis. Meta-regression analysis indicated that the difference in BMI z score between the nutrition specialist-only category and the reference category was significant at 3 to <6 months, 6 months to <1 year, and 1-year to 2-year time points (P=0.01, P=0.05, and P=0.01, respectively). There were smaller increases in BMI over time for the nutrition specialist-only provider category compared with reference categories, and this difference was significant at the 3 to <6 months and 1-year to 2-years time points (P=0.001 and P=0.05, respectively). There were no significant differences among provider categories for waist circumference at any time point.Conclusions
Indirect evidence indicated that pediatric weight management outcomes for BMI z score and BMI at selected time points appeared to be better when a nutrition specialist was involved in delivering care. 相似文献8.
目的评估头针联合工娱治疗对脑卒中后偏身功能障碍治疗的临床效果。方法选取2015年1月—2018年12月期间大连市友谊医院康复科病房收治的90例脑卒中恢复期存在偏身功能障碍的患者,病程在30~90 d,采取随机的方法,分为头针组30人,工娱组30人;综合组(头针联合工娱治疗组)30人。3组均给予运动疗法训练。头针组予头针治疗;工娱组予工娱治疗;综合组予头针+工娱治疗。治疗周期为4周,采用MAS运动量表进行肢体功能评定,比较3组临床疗效。经过四周的治疗后,三组患者治疗后MAS运动量表评分高于同一组治疗前评分,差异有统计学意义(P<0.05);3组患者治疗后MAS运动量表评分比较,综合组明显高于头针组及工娱组,差异有统计学意义(P<0.01)。结论头针联合工娱治疗可显著改善脑卒中后患者偏身功能障碍。 相似文献
9.
Gregory Lazarian Shanye Yin Elisa ten Hacken Tomasz Sewastianik Mohamed Uduman Alba Font-Tello Satyen H. Gohil Shuqiang Li Ekaterina Kim Heather Joyal Leah Billington Elizabeth Witten Mei Zheng Teddy Huang Mariano Severgnini Valerie Lefebvre Laura Z. Rassenti Catherine Gutierrez Catherine J. Wu 《Cancer cell》2021,39(3):380-393.e8
10.
目的 探讨益气补肾方含药血清对人胃癌细胞SGC-7901增殖转移能力及CD44+EpCAM+干细胞比例的影响。方法 分别以低、中、高不同浓度益气补肾方含药血清及空白血清干预人胃癌细胞SGC-7901。采用MTT法检测24,48,72 h细胞增殖抑制率,Transwell小室检测胃癌细胞迁移侵袭能力。采用5-氟尿嘧啶(5-Fu)共培养富集胃癌干细胞,流式细胞术检测药物干预后CD44+EpCAM+干细胞比例。结果 干预48,72 h后,益气补肾方组细胞增殖抑制率显著高于同时期阴性对照组及空白对照组,差异有统计学意义(P<0.05)。Transwell结果显示,与阴性对照组和空白对照组比较,益气补肾方各组透膜细胞数显著降低,迁移能力受明显抑制,差异有显著统计学意义(P<0.01)。流式细胞术结果显示,终浓度为20 μg·mL-1的5-Fu共培养24 h后,胃癌干细胞比例显著提升,益气补肾方干预后各组细胞中CD44+EpCAM+干细胞比例均下调,中、高浓度组与模型对照组相比,差异有显著统计学意义(P<0.01)。结论 益气补肾方含药血清能显著抑制人胃癌细胞SGC-7901增殖,并呈时间、剂量相关性,其抗转移作用可能与下调胃癌干细胞表面标志物CD44、EpCAM表达,降低CD44+EpCAM+干细胞比例有关。 相似文献